Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Cash & Current Investments of $10.1 million for Q1 2026, down 39.99% year-over-year from $16.9 million in Q1 2025, and down 8.13% quarter-over-quarter from $11.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Cash & Current Investments data on file, last reported at $10.1 million in Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $10.1 million, down 39.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.1 million (down 39.99% YoY), and the FY2025 annual result was $11.0 million, down 43.42% from the prior year.
  • Cash & Current Investments fell to $10.1 million in Q1 2026 per SLGL's latest filing, from $11.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $28.0 million in Q4 2023 and troughed at $6.2 million in Q2 2022.
  • A 5-year average of $14.0 million and a median of $13.4 million in 2024 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments tumbled 80.39% in 2022, then surged 135.28% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $21.1 million in 2022, then surged by 32.46% to $28.0 million in 2023, then sank by 30.31% to $19.5 million in 2024, then slumped by 43.42% to $11.0 million in 2025, then decreased by 8.13% to $10.1 million in 2026.
  • Business Quant data shows SLGL's Cash & Current Investments at $10.1 million in Q1 2026, $11.0 million in Q4 2025, and $6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 10.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Dec 31, 2025 11.03 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 10.22 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 19.50 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 17.55 Mn
Mar 31, 2024 11.21 Mn
Dec 31, 2023 27.98 Mn
Sep 30, 2023 14.14 Mn
Jun 30, 2023 14.62 Mn
Mar 31, 2023 6.81 Mn
Dec 31, 2022 21.13 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 6.21 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 43.35 Mn
Jun 30, 2021 11.65 Mn